NCT02161978View on ClinicalTrials.gov

Vascular Dysfunction and Antiangiogenic Therapy

CompletedOBSERVATIONAL
Enrollment

93

Participants

Timeline

Start Date

February 9, 2012

Primary Completion Date

December 12, 2018

Study Completion Date

December 12, 2018

Conditions
Solid TumorTumor AngiogenesisEndothelial DysfunctionCML (Chronic Myelogenous Leukemia)
Trial Locations (1)

49933

University Hospital Angers, Angers

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT02161978 - Vascular Dysfunction and Antiangiogenic Therapy | Biotech Hunter | Biotech Hunter